CooperSurgical
Changing fertility care for generations to come At CooperSurgical, we are continuing to push the boundaries of what is possible to build a better journey for all, to change fertility care for generations to come. This means changing fertility standards, the fertility journey, and providing better access globally to fertility treatments. We will do this by continuing to deliver solutions for different patients’ needs, and by collaborating closely with clinics worldwide to standardize, optimize and automize clinical workflows. We will help clinics reach a higher level of efficiency and insight throughout the entire fertility journey, by bringing scientifically based best practices into day-to-day care, utilizing digital platforms and artificial intelligence. This is how CooperSurgical, together with you, will help change fertility care. Not just today, but for generations to come. Visit our websites to find out more at fertility.coopersurgical.com.
CooperSurigcal, Inc.
75 Corporate Drive
Trumbull, CT 06611
USA Phone: +45 46790200
Email: [email protected]
URL: fertility.coopersurgical.com
Illumina
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. Through innovation and collaboration with health care providers and clinical laboratories, we are enabling genomic breakthroughs and using whole-genome sequencing to shorten the patient diagnostic odyssey. At Illumina, we support global efforts for projects that create equitable genome representation, so all populations can benefit from the full health potential of genomic research. We’re empowering our partners to predict and prevent disease, make personalized medicine a reality, and help people understand more about themselves. And this is only the beginning.
Illumina Netherlands BV
Steenoven 19
5626 DK Eindhoven
The Netherlands
VAT NL815505620B01
Company registration Nb: 17188953
Revvity
We are immensely excited to share with you that we are Revvity, a visionary partner in developing technologies and solutions across disease pathways to help solve the world’s greatest health challenges.
The meaning behind Revvity
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents our commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere. We provide health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Your challenge is our call to action
We specialize in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Every day, our 11,000 employees worldwide collaborate to pioneer technologies, solutions, and services that help you, our customers, redefine the health of our world. With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.
Revvity exists to expand the boundaries of human potential through science. Together with our customers and partners we will bring our purpose to life.
Revvity (UK) Ltd.
Llantrisant Business Park
Llantrisant Pontyclun
Rhondda Cynon Taff
Wales
CF72 8YW
www.revvity.com – Revvity – Expanding the boundaries of human potential through science
Phone: UK: 0800 89 60 46
Contact Form – https://www.revvity.com/gb-en/contact-us/customer-care
ARCEDI
ARCEDI Biotech is an emerging leader in noninvasive prenatal diagnostics with the development of EVITA TEST COMPLETE, world’s first fetal cell-based noninvasive prenatal test. This breakthrough innovation provides access to the intact fetal cell and pure fetal DNA without causing distress or discomfort to the pregnant woman or pose any risk to the fetus. Based on a simple blood sample taken 10-14 weeks of gestation, timely access to the complete genetic information can provide peace of mind, enable informed decision making as well as prepare for optimal management of the pregnancy.
ARCEDI Biotech
Tabletvej 1. 7100
Vejle Denmark
Phone: +45-28717247
URL: www.arcedi.com
BGI
BGI Genomics is the world’s leading integrated solutions provider of precision medicine, now serving customers in more than 100 countries, involving over 2,300 medical institutions.
Relying on cutting-edge sequencing and bioinformatics technology, we provide our customers with expert and affordable clinical molecular diagnostic solutions and high-throughput sequencing (NGS) research services.
BGI Genomics
Symfonivej 34, 2730 Herlev, Denmark
URL: https://www.bgi.com/global
CeGaT
CeGaT GmbH
Paul-Ehrlich-Str. 23
72076 Tubingen, Germany
Email: [email protected]
Website: cegat.de
